Spain (ES)

Clinical implementation of RNA sequencing for Mendelian disease diagnostics (2022) Yépez VA, Gusic M, Kopajtich R, Mertes C, Smith NH, Alston CL, Ban R, et al. Journal article Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis (2022) Siafis S, Ciray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, et al. Journal article Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk (2022) Boehm M, Schumacher H, Werner C, Teo KK, Lonn EM, Mahfoud F, Speer T, et al. Journal article Reviews and syntheses: A framework to observe, understand and projectecosystem response to environmental change in the East Antarctic SouthernOcean (2022) Gutt J, Arndt S, Barnes DKA, Bornemann H, Brey T, Eisen O, Flores H, et al. Journal article, Review article Has the COVID-19 Pandemic Led to Changes in the Tasks of the Primary Care Workforce? An International Survey among General Practices in 38 Countries (PRICOV-19) (2022) Groenewegen P, Van Poel E, Spreeuwenberg P, Batenburg R, Mallen C, Murauskiene L, Peris A, et al. Journal article Switchable chiral transport in charge-ordered kagome metal CsV3Sb5 (2022) Guo C, Putzke C, Konyzheva S, Huang X, Gutierrez-Amigo M, Errea I, Chen D, et al. Journal article CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Large Real-World Series from Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2022) Brissot E, Peczynski C, Labopin M, Lussana F, Hough R, Kuball J, Rösler W, et al. Conference contribution Trends in the Use of Hematopoietic Stem Cell Transplantation in the Management of Relapsed/Refractory Diffuse Large B Cell Lymphoma. a Retrospective Analysis of the Lymphoma Working Party of the EBMT (2022) Sureda A, Boumendil A, Berning P, Finel H, Caillot D, Rösler W, Finke J, et al. Conference contribution Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study (2022) Wong SW, Bar N, Paris L, Hofmeister CC, Hansson M, Santoro A, Mateos MV, et al. Conference contribution Inferior Outcomes of EU Vs. US Patients with Relapsed/Refractory Large B-Cell Lymphoma after CD19 CAR T-Cell Therapy Are Associated with Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization and CAR-T Product Selection (2022) Buecklein VL, Perez-Perez A, Rejeski K, Iacoboni G, Jurinovic V, Holtick U, Penack O, et al. Conference contribution